administered over several days, inpatient status during this period represents a significant contribution to the cost of transplantation. We have retrospectively reviewed the ability to safely deliver total body irradiation (TBI) in the outpatient Algara et al 2 have previously described the safe administration of TBI to four adult patients on an outpatient basis setting in 10 pediatric patients undergoing stem cell transplantation. Patients had a median age of 14 years which resulted in cost savings of $1160 per patient. With (1) the advent of new and effective antiemetics; 3-5 (2) the (range 9-17 years) with diagnoses that included ALL in second remission, AML in second remission, myelodincreasing sophistication of home care provider services; and (3) the need for cost-containment, the administration ysplastic syndrome, Ewing's sarcoma, and rhabdomyosarcoma. Patients received a total of 1375 cGy or of outpatient TBI was evaluated in a pediatric population. We conducted a retrospective chart review of all pedi-1440 cGy given in a hyperfractionated schedule (11 or 12 fractions) over a 4-day period. All children were seen atric patients at Riley Hospital for Children who received outpatient TBI as part of a preparative regimen for stem in the outpatient clinic daily during TBI and all were housed within a 20 mile radius of our institution during cell transplantation. Our purpose was to evaluate the safety, feasibility, and cost of outpatient TBI in this population. this period. Eight patients achieved good control of nausea and emesis with ondansetron alone while two patients required ondansetron and diphenhydramine.
auto/PSC = autologous peripheral blood progenitor cells; cord/URD = unrelated donor cord blood; BM/MRD = matched related donor bone marrow; BM/URD = unrelated donor bone marrow; syngeneic = syngeneic bone marrow; RA = refractory anemia.
(RMH) two blocks from the hospital and one patient was Discussion at home (Ͻ20 miles from the hospital) in between treatment days. In between individual treatment sessions patients
We have initiated the use of outpatient TBI in selected pediatric patients in an effort to reduce time in the hospital as returned to the RMH or remained in the radiation facility waiting room. All children were seen in the outpatient well as costs. Older pediatric patients received outpatient TBI if they were clinically stable without medical problems clinic daily during TBI.
On the first day of TBI, patients had a median white that might be complicated during radiation therapy (eg active infection, bulky or relapsed disease) and able to count of 2800/mm 3 (range 1900-5700) and a median absolute granulocyte count of 2280/mm 3 (range 1100-3760). cooperate with the TBI procedure without sedation. Nausea and vomiting were well controlled with ondanseThe median hemoglobin was 11.0 gm/dl (range 8.0-12.0) and the median platelet count was 153 × 10 3 /mm 3 (range tron with the occasional addition of benadryl in our patient population. However, maintenance of adequate hydration 47-367 × 10 3 ). None of these patients required transfusion of platelets or packed red blood cells during their TBI with oral intake alone proved to be problematic in this pediatric population. When we started our practice of delivering regimen.
Costs were estimated based upon routine daily bed outpatient TBI, children received no planned intravenous fluid supplementation. Two of the first four of these chilcharges and transportation to and from the radiation facility for inpatients while taking into account outpatient charges dren required fluid boluses during clinic visits and one child required inpatient admission. We subsequently instituted for clinic visits, fluid administration, and home-care nursing. The cost of anti-emetics administered in both settings the administration of night-time intravenous fluids for all children not already receiving hyperalimentation and subwas equal.
All data collected were descriptive in nature. No inferensequently all six children were able to maintain adequate hydration with completion of TBI as an outpatient. Our tial statistical analyses were performed. experience suggests that nightly supplemental intravenous fluid administration (hyperalimentation or intravenous Results fluids) may allow for sufficient hydration such that TBI can be administered in an outpatient setting. Eight patients achieved good control of nausea and emesis with ondansetron (4-8 mg four times a day i.v. or orally)
Our current practice is to consider outpatient TBI in children without acute medical problems who have a developalone while two patients required ondansetron and diphenhydramine. Six patients received oral ondansetron mental age greater than or equal to 8 years and who do not require anesthesia or sedation for TBI administration. Any while four patients required intravenous ondansetron. Two patients continued to receive night-time hyperalimentation attempt to extend the practice of outpatient TBI to younger children must take into account the need for sedation or during this period for pre-existing poor nutritional status. Two patients received fluid boluses during routine clinic anesthesia in order to deliver radiation. The only other published report of the use of outpatient visits for inadequate oral intake. Four patients received night-time intravenous fluids over 10 h during the period TBI for stem cell transplantation was confined to adults. Four of five patients described by Algara et al 2 tolerated of outpatient TBI. One patient maintained good hydration with oral intake alone. Only one child required admission outpatient TBI using oral ondansetron as an anti-emetic and one patient required admission for nausea and vomiting. during this period for persistent nausea and vomiting despite anti-emetics and intravenous fluids given in the outThey reported a cost savings of $1160 per patient. In our series of 10 pediatric patients, we took into account hospital patient clinic. This patient had not received any planned intravenous fluid supplementation and was admitted on day bed charges and transportation costs relevant to the inpatient setting and home-care nursing, clinic visits, and 3 of 4 of her TBI regimen. A cost approximation suggests that TBI delivered in the outpatient setting resulted in a fluid administration costs relevant to the outpatient setting. TBI delivered in the outpatient setting is estimated to result savings of approximately $2400 per patient.
